ValiRx plc (GB:VAL) has released an update.
ValiRx plc, a life science company focusing on cancer therapeutics and women’s health, invites shareholders and potential investors to an engaging Investor Evening on 24 September 2024. The event, organized by Shard Capital Partners LLP, will feature a presentation and Q&A with CEO Dr. Mark Eccleston and offers an opportunity for in-depth company insights and networking over drinks.
For further insights into GB:VAL stock, check out TipRanks’ Stock Analysis page.
